share_log

Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update

SEC ·  Aug 2 05:12
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.